We at NIA have again issued a Notice advertising a program through which NIH grantees can apply for administrative supplements to add Alzheimer’s disease and related dementias (AD/ADRD) research components to grants that are not currently focused on AD.
NIA is the largest public funder of Alzheimer’s disease and related dementias (AD/ADRD) research in the U.S.
At NIA, we know that achieving and maintaining good health is about more than biology.
Are you a late post-doc looking for a career in aging research? Or a junior faculty member looking to expand your career options?
Austin, TX, is the scene for the 2019 annual meeting of the Gerontological Society of America on November 13–17.
In what now seems ancient times, NIA took drastic action on how we reviewed program projects (P01s). It is extraordinary to recall, but in those distant years through 2016, program projects began to collect perfect or near-perfect review scores with uncanny frequency.
Wonders from a developing world: a pediatric ventilator made from a shampoo bottle and plastic tubing.
We’ve come around again to the start of a new fiscal year (FY), and that means it’s time for an update on where the NIA budget currently stands and an attempt to forecast the climate for funding in FY 2020.
We know that travel budgets are tight for many researchers, especially for students and junior faculty. To help, we enjoy taking the NIA show on the road to meet face to face with scientists who are conducting research to better understand aging from a range of perspectives and disciplines.
People with Alzheimer’s disease and Alzheimer’s disease-related dementias (AD/ADRD) and those who care for them urgently need evidence-based help that can be used in the real world.
NIA is excited to unveil our latest collection of cleared concepts for funding opportunity announcements (FOAs).